Physician profile
Andrew Fireman
NPI 1457349433
$3,702.24
in general payments reported to CMS, 2019-2025
32 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,214 · 2020: $454 · 2021: $296 · 2022: $427 · 2023: $301 · 2024: $478 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,311.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $719.36 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $377.47 | 2019-2024 | Watchman Access System |
| Pfizer INC. | $298.69 | 2019-2023 | |
| Amgen INC. | $241.05 | 2019-2025 | Repatha, Repatha |
| Abiomed | $235.26 | 2021-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $216.21 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $198.12 | 2019-2023 | |
| Abbott Laboratories | $187.74 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Assurity |
| Cvrx, INC. | $168.58 | 2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals Lp | $131.61 | 2019-2024 | Farxiga, Wainua |
| Medtronic Vascular, INC. | $125.24 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $120.39 | 2019-2024 | Eliquis |
| Impulse Dynamics (USA) INC. | $101.47 | 2023 | Optimizer |
| W. L. Gore & Associates, INC. | $58.44 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.21 | 2019-2025 | Lifevest |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $55.53 | 2019-2020 | |
| Edwards Lifesciences Corporation | $45.98 | 2019 | |
| Daiichi Sankyo INC. | $42.50 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.99 | 2019-2022 | |
| Atricure, INC. | $37.22 | 2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Merck Sharp & Dohme LLC | $37.00 | 2023-2025 | Verquvo |
| Janssen Biotech, INC. | $32.73 | 2020 | |
| Novo Nordisk INC | $23.19 | 2025 | Wegovy |
| Endotronix, INC. | $22.53 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
| Alnylam Pharmaceuticals INC. | $21.64 | 2025 | Onpattro |
| La Jolla Pharmaceutical Company | $19.60 | 2025 | Giapreza |
| Inspire Medical Systems, INC. | $17.95 | 2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $17.48 | 2024 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals, Ltd. | $13.41 | 2023 | Arcalyst |
| Clearflow INC. | $13.01 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $11.82 | 2019 | |
| Ge Healthcare | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Fireman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.